(Q53379267)

13 May 2018

title

What treatments do patients with panic disorder and agoraphobia get? (English)

1 reference

13 May 2018

0 references

0 references

1

1 reference

13 May 2018

author name string

K Sievert

2

1 reference

13 May 2018

M Röthemeyer

3

1 reference

13 May 2018

G Hajak

4

1 reference

13 May 2018

E Rüther

5

1 reference

13 May 2018

publication date

1 January 1995

1 reference

13 May 2018

European Archives of Psychiatry and Clinical Neuroscience

published in

1 reference

13 May 2018

volume

245

1 reference

13 May 2018

page(s)

165-171

1 reference

13 May 2018

issue

3

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1007/bf02193090

exact match

0 references

cites work

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment

1 reference

https://api.crossref.org/works/10.1007%2FBF02193090

Agoraphobia with panic attacks. Development, diagnostic stability, and course of illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02193090

The assessment of anxiety states by rating

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02193090

Panic and avoidance in agoraphobia. Application of path analysis to treatment studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02193090

Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02193090

Use of medication and in vivo exposure in volunteers for panic disorder research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02193090

A Comparison of Fluvoxamine, Cognitive Therapy, and Placebo in the Treatment of Panic Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02193090

Validation criteria for panic disorder as a nosological entity

21 January 2018

1 reference

12 December 2020

Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine.

1 reference

12 December 2020

A controlled study of alprazolam and propranolol in panic-disordered and agoraphobic outpatients.

1 reference

12 December 2020

Use of benzodiazepines in anxiety disorders

1 reference

12 December 2020

Use of medical services and treatment for panic disorder with agoraphobia and for social phobia

1 reference

12 December 2020

Imipramine and Brief Therapist-Aided Exposure in Agoraphobics Having Self-exposure Homework

1 reference

12 December 2020

Hypnosis and Desensitization for Phobias: A Controlled Prospective Trial

1 reference

12 December 2020

Clomipramine treatment of agoraphobic women. An eight-week controlled trial

1 reference

12 December 2020

Is panic disorder a distinct diagnostic entity? A critical review of the borders of a syndrome

1 reference

12 December 2020

Benzodiazepine treatment of panic and agoraphobic symptoms: use, dependence, toxicity, abuse

1 reference

12 December 2020

Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale.

1 reference

12 December 2020

A comparison of alprazolam and behavior therapy in treatment of panic disorder

1 reference

12 December 2020

The social validity of treatments for agoraphobia

1 reference

12 December 2020

Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators

1 reference

12 December 2020

Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks

1 reference

12 December 2020

Combined pharmacological and behavioral treatment for agoraphobia

1 reference

12 December 2020

Panic, agoraphobia, and panic disorder with agoraphobia. Data from a multicenter anxiety disorders study

1 reference

12 December 2020

Two-year follow-up of exposure and imipramine treatment of agoraphobia

1 reference

12 December 2020

Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02193090

1 reference

13 May 2018

PubMed ID

7669824

1 reference

13 May 2018